Influence of the COVID-19 Pandemic on Dutch Surgical Patterns of Care

Completed

• Conditions: COVID-19

• Registration Number: NCT05126498
• Lead Sponsor: University Medical Center Groningen

Brief Summary

The aim of this study is to determine the impact of the COVID-19 pandemic on the Dutch surgical care, expressed as number of performed procedures, altered treatment plans, and surgical outcomes in the Netherlands during the year 2020.

Detailed Description

The aim of this study is to determine the impact of the COVID-19 pandemic on the Dutch surgical care, expressed as number of performed procedures, altered treatment plans, and surgical outcomes in the Netherlands during the year 2020. This was done by executing a nationwide prospective cohort study, under the name "Dutch COVIDsurg II Snapshot Study". This study was conducted in collaboration with the Dutch Institute of Clinical Auditing (DICA). For this study, the surgical audits for lung cancer surgery (DLCA-S), Upper gastrointestinal cancer surgery (DUCA), pancreatic cancer surgery (DPCA), hepatobiliary surgery (DHBA), colorectal cancer surgery (DCRA), hip fracture surgery (DHFA), aortic aneurysm surgery (DSAA), and bariatric surgery (DATO), were expanded with an additional COVID-19 survey, since August 2020. This survey focused on alterations in, or delay of treatment and diagnostics, perioperative outcomes, and specific COVID-19 related symptoms and complications during the COVID-19 pandemic. All academic-, general community-, teaching- and non-teaching hospitals in the Netherlands performing pulmonary, upper gastrointestinal, pancreatic, hepatobiliary, colorectal, hip fracture, aneurysmal or bariatric procedures were approached to participate in the Dutch COVIDSurg II Snapshot study. Patients who underwent surgery during the period January 1st 2018 until December 31st 2019, were included in the historical cohort. Patients who underwent a surgical procedure in the period January 1st 2020 until December 31st 2020 were included in the study group.

Study Timeline

• Study Start: 2020-08-01
• Primary Completion: 2021-05-01
• Study Completion: 2021-05-01
• Study First Submitted: 2021-11-16
• Study First Submitted QC: 2021-11-18
• Study First Posted: 2021-11-19
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-14
• Last Update Posted: 2024-04-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40296

Inclusion Criteria

• All patients who underwent pulmonary, upper gastrointestinal, pancreatic, hepatobiliary, colorectal, hip fracture, aneurysm or bariatric surgery
• Alle patients >18 years
• Patients undergoing surgery during the period January 1st 2018 until December 31st 2020
• Hospital that performs the surgery has to participate in the study

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of performed surgical procedures	2018-2020	The data on surgical outcomes was collected through the database of the Dutch Institute for Clinical Auditing

Secondary Outcome Measures

Name	Time	Method
Length of hospital stay (days)	2018-2020	Data was collected through an additional COVID-19 survey and through the database of the Dutch Institute for Clinical Auditing
30-day hospital readmissions (percentage)	2018-2020	Data was collected through an additional COVID-19 survey and through the database of the Dutch Institute for Clinical Auditing
severe complications (Clavien-Dindo grade > 3A)	2018-2020	Severe complications are defined as Clavien-Dindo grading system; Data was collected through an additional COVID-19 survey and through the database of the Dutch Institute for Clinical Auditing
ICU admission (percentage)	2018-2020	Data was collected through an additional COVID-19 survey and through the database of the Dutch Institute for Clinical Auditing
length of ICU stay (days)	2018-2020	Data was collected through an additional COVID-19 survey and through the database of the Dutch Institute for Clinical Auditing
mortality rate (percentage)	2018-2020	Data was collected through an additional COVID-19 survey and through the database of the Dutch Institute for Clinical Auditing; Mortality is defined as mortality during hospital stay or within 30 days after surgery

Trial Locations

Locations (1)

UMCG; 🇳🇱 Groningen, Netherlands